CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880277072
- Phone
- (713) 400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- 10-Q Report Quarterly Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Unregistered share sale · Other events
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Agreement ended · Executive or director change
- 8-K Event Bylaws or fiscal year change
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- POS AM Other Post-effective Amendment for Registration Statement
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- 10-Q/A Report 10-Q/A
- 10-Q/A Report 10-Q/A
- 10-Q/A Report 10-Q/A
- 8-K Event Restatement
- NT 10-K Other NT 10-K
Page 24 of 46 · 904 filings